Clene Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.29

+0.37 (+9.44%)

As of Feb 8, 2:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +339.6% upside

Low Target $15.04

Average Target $18.86

High Target $28.67

Current Price $4.29

Current
$4.29

Target
$18.86

$15.04 $18.86 avg $28.67

Scenario Analysis

Bear Case

$15.04

250.6%

Low target

Base Case

$18.86

+339.6%

Avg target

Bull Case

$28.67

+568.3%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$22.76

-81.2% from high

52-Week Low

$12.16

+-64.7% from low

Target vs 52W High

$18.86

-17.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%